Protalix BioTherapeutics
PLX
#8714
Rank
$0.10 B
Marketcap
$1.41
Share price
13.71%
Change (1 day)
2.92%
Change (1 year)

Protalix BioTherapeutics (PLX) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : $62.95 Million USD

According to Protalix BioTherapeutics 's latest financial reports the company's total liabilities are $62.95 Million USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Protalix BioTherapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31$50.86 M-23.43%
2022-12-31$66.42 M-16.65%
2021-12-31$79.7 M-16.08%
2020-12-31$94.97 M-17.93%
2019-12-31$0.11 B1.49%
2018-12-31$0.11 B12.14%
2017-12-31$0.10 B10.27%
2016-12-31$92.2 M6.74%
2015-12-31$86.38 M-35.52%
2014-12-31$0.13 B-4.51%
2013-12-31$0.14 B70.9%
2012-12-31$82.08 M5.4%
2011-12-31$77.88 M2.41%
2010-12-31$76.05 M-8.14%
2009-12-31$82.78 M1180.75%
2008-12-31$6.46 M45.19%
2007-12-31$4.45 M64.64%
2006-12-31$2.7 M139.29%
2005-12-31$1.13 M1491.55%
2004-12-31$0.07 M-9.92%
2003-12-31$0.07 M-0.32%
2002-12-31$0.07 M2.33%
2001-12-31$0.07 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
$0.60 B 865.28%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.81 B 1,196.24%๐Ÿ‡บ๐Ÿ‡ธ USA
$126.91 B 201,488.34%๐Ÿ‡บ๐Ÿ‡ธ USA
$35.37 B 56,085.77%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel